Diagnostic Imaging's Weekly Scan: February 22 — February 28

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In a recent interview with Diagnostic Imaging, Nina Kottler, M.D., discussed the agility of agentic AI to achieve system-level goals in radiology, the need for transparency and how agentic AI may affect the future of radiology.

The use of adjunctive AI led to higher detection of breast cancer in women with dense breasts as well as increased detection of invasive cancer and lobular cancer, according to new research involving over 100,000 screening DBT exams.

In another recent interview with Diagnostic Imaging, Jeremy Heit, M.D., Ph.D., discussed key neuroimaging takeaways from changes to the updated guideline from the American Heart Association and the American Stroke Association for early evaluation and management of patients with acute ischemic stroke.

In a recent interview from the ASCO-GU conference. Daniel George, M.D., discussed new study findings with ¹⁷⁷Lu-PSMA-617 (Pluvicto, Novartis) for the treatment of older taxane-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) and potential implications for future research.

Radiologist turnover continues to be a significant challenge with higher turnover rates among women, metropolitan radiologists and those in non-academic settings, according to newly published research in the Journal of the American College of Radiology.